World’s First Achievement Highlights Brand Leadership
Release time:
2026-01-19
On January 16, the Shandong Brand Annual Conference and the Third Session of the Second Member Congress were grandly held at the Nanjiao Hotel in Jinan. During the conference, the results of the annual brand building selection were announced. Shandong Yinfeng Life Science Research Institute (hereinafter referred to as "Yinfeng Life Science Research Institute") was awarded the "Outstanding Case in Brand Building" for its world-first "Ovarian Dual-Activation" technology project. Additionally, Liu Zhicheng, Vice President of Yinfeng Life Science Research Institute, was honored with the title of "Brand Innovation Figure." This award not only recognizes the institute's capabilities in technological innovation and transformation but also showcases Yinfeng's brand strength in the forefront of life sciences.
As a significant milestone in the Yinfeng Life Continuation Plan, the "Ovarian Dual-Activation" technology represents a major breakthrough at the intersection of cryogenic biomedicine and reproductive medicine. This technology innovatively dual-activates the ovaries through the "Primordial Follicle In Vitro Balanced Vitrification Freezing Activation Technology + Autologous Vein-Derived Cytokine Technology," successfully overcoming the technical challenges of restoring ovarian function in patients with premature ovarian failure. In June 2025, the first healthy baby benefiting from this technology was born. The application of this technology provides safe, effective, and personalized treatment options for patients with premature ovarian insufficiency (POI) and poor ovarian response (POR), while also offering a new technological choice for preserving fertility in cancer patients.
Since its introduction, this technology has received acceptance for two national invention patents. Recognized as a "Jinan Excellent Achievement," it was selected for the Shandong Provincial Department of Science and Technology's 2025 "Shandong Excellent Achievements Report" project. It has been widely covered by media outlets such as China News of Traditional Chinese Medicine, Health News, and other mainstream platforms, demonstrating Yinfeng's solid ability to efficiently translate cutting-edge research into social recognition and brand influence.
This award further solidifies Yinfeng Life Science Research Institute's leading brand position in cryogenic biomedicine and life sciences, making it a highly recognizable name in the field of life sciences under the "Science and Technology Innovation Shandong" initiative.
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Previous article
Previous article
Latest developments
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
According to the latest announcement from the International Society of Cryobiology, Professor Xu Yi from the School of Health Science and Engineering at the University of Shanghai for Science and Technology, and a member of the Yinfeng Cryomedicine Expert Committee, has been elected as a Board Governor of the Society for a three-year term (2026–2028). The election was conducted through a democratic vote by all members worldwide, with three new Board Governors elected. Professor Xu Yi is the only scholar from Asia elected to the Society’s Board of Governors this time and the third elected scholar from mainland China in the Society’s 60-year history.
The significance of life extension lies not only in technological breakthroughs but also in the shared belief of every individual who believes in "a better future." With faith as their torch, these fellow travelers join hands, pooling their strength to stride forward together. We firmly believe that as this steadfast support converges into a powerful force, it will propel the Yinfeng Life Extension Plan to gain broader attention, inject continuous momentum into the development of cryobiomedicine, and illuminate the next chapter of human civilization.
Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.
According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
